IL-4 Promotes NLRP3 Nuclear Localization in Malignant CD4+ T Cells, and Tumor Lesions Show Augmented NLRP3 Expression in CTCL. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.